8-K: Mativ Q2 2025: Sales Up, Cash Flow Strong

Mativ Holdings, Inc. reported a 0.3% increase in Q2 2025 sales to $525.4 million, alongside significant year-over-year growth in adjusted EBITDA and free cash flow.

Summary

• Consolidated sales for Q2 2025 were $525.4 million, a 0.3% increase year-over-year, with organic sales growth of 2.6%.
• GAAP net loss for Q2 2025 was $9.5 million, resulting in a GAAP EPS of $(0.18).
• Adjusted EBITDA for Q2 2025 increased 1% year-over-year to $67.2 million.
• Adjusted income was $18.5 million, and Adjusted EPS was $0.33.
• Cash from operating activities for Q2 2025 was $57.6 million, up 25% from the prior year.
• Free cash flow for Q2 2025 was $48.9 million, up 33% from the prior year, marking the second-highest cash flow quarter since the merger.
• The Filtration & Advanced Materials (FAM) segment sales were $204.4 million, down 1.0% year-over-year, primarily due to lower selling prices and volume/mix.
• The Sustainable & Adhesive Solutions (SAS) segment sales were $321.0 million, up 1.1% reported and 5.0% on an organic basis, driven by higher organic volume and selling prices.
• Total debt as of June 30, 2025, was $1,090.6 million, with net debt at $995.0 million.
• Total liquidity was approximately $453 million, comprising $96 million in cash and $357 million in revolver availability.
• A quarterly cash dividend of $0.10 per share was announced, payable on September 26, 2025.
• Year-to-date 2025 net loss was $(435.0) million, primarily due to a $411.9 million goodwill impairment expense.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive. While GAAP results show a loss and a significant goodwill impairment, the company emphasizes strong adjusted EBITDA growth, substantial free cash flow generation, and organic sales growth in a key segment. Management commentary is confident about operational execution and future improvements, indicating a focus on underlying business health despite accounting charges.

Positives

• Overall sales increased by 0.3% year-over-year to $525.4 million, with a stronger organic growth rate of 2.6%.
• Adjusted EBITDA grew by 1% year-over-year to $67.2 million, driven by lower SG&A expenses and higher organic volume in the SAS segment.
• Cash from operating activities significantly increased by 25% year-over-year to $57.6 million in Q2 2025.
• Free cash flow saw a substantial 33% year-over-year increase to $48.9 million, marking the second-highest cash flow quarter since the company's merger.
• The Sustainable & Adhesive Solutions (SAS) segment demonstrated strong organic sales growth of 5.0% and a 1.1% reported sales increase to $321.0 million.
• Unallocated GAAP operating expenses decreased by $3.0 million, and Adjusted unallocated expenses (EBITDA) decreased by $3.2 million, primarily due to lower SG&A.
• The company maintains total liquidity of approximately $453 million, including $96 million in cash and $357 million in revolver availability.

Negatives

• GAAP net loss widened to $9.5 million in Q2 2025 from $1.4 million in Q2 2024.
• GAAP EPS declined to $(0.18) in Q2 2025 from $(0.03) in Q2 2024.
• Gross profit decreased by 4.8% year-over-year to $103.7 million in Q2 2025.
• The Filtration & Advanced Materials (FAM) segment experienced a 1.0% decline in sales to $204.4 million, primarily due to lower selling prices and volume/mix.
• FAM segment's Adjusted EBITDA decreased by 4.0% year-over-year to $40.6 million, impacted by higher manufacturing and distribution costs and unfavorable net selling price versus input cost performance.
• SAS segment's Adjusted EBITDA decreased by 1.9% year-over-year to $45.3 million, primarily due to higher manufacturing and distribution costs.
• The tax expense for Q2 2025 was 416.7%, driven by a change in valuation allowances and one-time adjustments.
• Year-to-date 2025 net loss was significantly higher at $(435.0) million compared to $(29.4) million in the prior year, largely due to a goodwill impairment charge of $411.9 million.
• Total stockholders' equity decreased from $858.5 million at December 31, 2024, to $416.6 million at June 30, 2025, primarily due to the goodwill impairment.

Risks

• Risks associated with the implementation of strategic growth initiatives, including diversification and entry into new industries and technologies.
• Risks associated with acquisitions, dispositions, strategic transactions, and global asset realignment initiatives.
• Adverse changes in end-market sectors impacting key customers.
• Changes in the source and intensity of competition in commercial end-markets.
• Adverse changes in sales or production volumes, pricing, and/or manufacturing costs.
• Seasonal or cyclical market and industry fluctuations leading to reduced net sales and operating profits.
• The possibility that current technological advantages in intellectual property may not continue indefinitely.
• Supply chain disruptions, including the failure of material suppliers (energy, resin, fiber, chemical).
• Increases in operating costs due to inflation, labor expense, compensation, and benefits.
• Ability to attract and retain key personnel, labor shortages, strikes, stoppages, or other disruptions.
• Changes in general economic, financial, and credit conditions in the U.S., Europe, China, and elsewhere, including impacts on currency exchange rates (e.g., weakening Euro) and interest rates.
• Failure in risk management and/or currency or interest rate swaps and hedging programs.
• Changes in the manner of financing debt and future capital needs, including potential acquisitions.
• Changes in tax rates, new U.S. or international tax legislation, or exposure to additional tax liabilities.
• Uncertainty regarding the long-term value of Mativ's common stock.
• Changes in employment, wage, and hour laws and regulations, including unionization rules and anti-discrimination rules.
• Impact of tariffs, future additional tariffs, other trade barriers, retaliatory trade measures, and tariff uncertainty on macroeconomic conditions.
• Existing and future governmental regulation and enforcement that may restrict business or affect financial results.
• Weather conditions, potential impacts from climate change, natural disasters, or unusual weather events.
• International conflicts and disputes, such as the ongoing conflict between Russia and Ukraine, the war between Israel and Hamas, and the broader regional conflict in the Middle East, which may restrict product supply, affect demand, or impact commercial activities.
• Compliance with the FCPA, other anti-corruption laws, trade control laws, and other governing operations.
• Risks associated with pandemics and other public health emergencies.
• Number, type, outcomes, and costs of legal, tax, regulatory, or administrative proceedings and litigation.
• Increased scrutiny from stakeholders related to environmental, social, and governance (ESG) matters and the ability to achieve broader ESG goals.
• Costs and timing of implementation of any upgrades or changes to information technology systems.
• Failure to comply with privacy or data security laws or to protect against theft of sensitive information.
• Information technology system failures, data security breaches, network disruptions, and cybersecurity events.

Future Outlook

Management expects to continue operating at an increased pace of execution, with a focus on generating strong year-over-year adjusted EBITDA and free cash flow improvement for the remainder of the year. A strategic portfolio review is underway to evaluate opportunities to strengthen the balance sheet and reduce the leverage profile.

Management Comments

• "We delivered solid results within both FAM and SAS segments and across the enterprise."
• "Mativ's second quarter results reflect a year over year growth in adjusted EBITDA as well as a significant sequential quarterly increase in both adjusted EBITDA and free cash flow."
• "Organic volume increases in our SAS segment together with disciplined cost and expense control led the year-over-year improvement in adjusted EBITDA, and our focus on cash flow and working capital optimization produced our second-highest cash flow quarter as Mativ."
• "We continue to operate at an increased pace of execution, and our strong performance in Q2 reflects the corresponding results."
• "Our strategic portfolio review is underway evaluating opportunities to supplement the work we are doing to strengthen our balance sheet and reduce our leverage profile, and our results to date have galvanized our team's focus on generating strong year-over-year adjusted EBITDA and free cash flow improvement for the remainder of the year."

Industry Context

Mativ operates in the specialty materials sector, providing solutions across filtration, advanced materials, and sustainable adhesive solutions. The company's performance reflects a challenging macro-economic environment, including tariff impacts, yet it managed to achieve organic growth in its Sustainable & Adhesive Solutions segment, indicating resilience in specific market niches. The ongoing strategic portfolio review suggests a proactive approach to optimizing its business in a dynamic industry landscape, potentially aligning with broader industry trends of portfolio optimization and focus on high-growth, high-margin areas.

Comparison to Industry Standards

• The filing does not provide specific comparable company or project data to assess against global benchmarks.
• The company's focus on 'disciplined cost and expense control' and 'working capital optimization' suggests an effort to maintain efficiency in line with best practices, especially given the 'challenging tariff and macro-economic environment.'
• The significant goodwill impairment charge, while a non-cash item, indicates a re-evaluation of past acquisitions' value, which could be a broader industry trend for companies that have grown through M&A in recent years.

Stakeholder Impact

• Shareholders: Will receive a quarterly cash dividend of $0.10 per share. The GAAP net loss and significant goodwill impairment could negatively impact book value and perception, but strong cash flow and adjusted profitability might reassure investors focused on operational performance.
• Employees: The company thanked its "capable and engaged global Mativ team" for their focus on commercial delivery and agility. Organizational realignment costs were mentioned, which could imply some internal restructuring, but no direct negative impact on employees was stated.
• Customers: The company aims to solve "customers most complex challenges" and focuses on "enhanced commercial delivery," suggesting continued commitment to customer needs.
• Creditors: The company's debt matures on a staggered basis between 2027 and 2029, and it maintains substantial liquidity ($453 million), which should provide comfort to creditors regarding its ability to meet obligations. The strategic portfolio review aims to reduce the leverage profile.

Next Steps

• Continue strategic portfolio review to strengthen the balance sheet and reduce leverage.
• Focus on generating strong year-over-year adjusted EBITDA and free cash flow improvement for the remainder of the year.
• Hold a conference call on August 7, 2025, to discuss Q2 2025 results.
• Pay quarterly cash dividend of $0.10 per share on September 26, 2025.

Key Dates

Recommendation

While Mativ reported a significant GAAP net loss driven by a goodwill impairment, its operational performance, as indicated by adjusted EBITDA growth and strong free cash flow generation, shows resilience. The company's focus on cost control, working capital optimization, and a strategic portfolio review to strengthen the balance sheet are positive signs. However, the decline in the FAM segment's sales and adjusted EBITDA, coupled with the overall GAAP loss, suggests ongoing challenges. The stock is a 'hold' as investors should monitor the execution of the strategic review and the company's ability to translate operational improvements into sustained GAAP profitability and leverage reduction in a challenging macroeconomic environment.

Keywords

Specialty Materials, Filtration Media, Advanced Films, Adhesive Solutions, Tapes, Labels, Specialty Paper, Packaging Solutions, Healthcare Solutions, Industrial Materials, Manufacturing, Financial Results, Earnings Report, SEC Filing, MATV, Mativ Holdings